| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |